SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : MIDL .... A Real Sleeper

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Binder who wrote (1809)7/1/1998 10:45:00 AM
From: lazarre  Read Replies (1) of 7039
 
<<<<The only trouble with something like this is that until the insurance companies accept
these new developments as well as new drugs, and consider them something other than
"experimental", the stocks will usually lie on the ground. >>>>

Binder, that's the same fate experienced by all biotech/biotech equipment firms. There are scores of publicly traded companies involved right now creating non-invasive techniques for diagnosing illness; they are either in the development stage or in various Phase/Clinical Trials.

The hysteria that grabbed the market over a few experimental cancer drugs in May tell you a little bit about how they can behave.

Getting back to MIDL; wouldn't a company with a promising product or one that was already producing revenues be better off just starting off fresh by initiating an IPO: BB or Nasdaq?

2) If it is feasible for MIDL and Company X to get together--who does the initiating? If its Midland, who specifically, do you think, at Midland would be the one to start a ball rolling?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext